FDA advisors endorse Alzheimer’s treatment Leqembi paving way for full approval this summer
Medicare has promised to broadly cover Leqembi, which costs $26,500 per year, if the FDA grants full approval of the treatment.
Source link
Medicare has promised to broadly cover Leqembi, which costs $26,500 per year, if the FDA grants full approval of the treatment.
Source link
